严重呼吸功能不全应用(SRI App):一项试点随机对照试验
本研究开发了用于移动设备的严重呼吸功能不全问卷(SRI)应用,并在60例慢性呼吸衰竭患者中开展随机对照试验,将该应用与经典纸质SRI进行比较。结果显示SRI应用是一种实用且接受度良好的工具,可完全避免缺失值,并建立了信度、收敛效度和区分效度。
要点
- SRI应用在慢性呼吸衰竭患者中实用且接受度良好。
- 使用SRI应用可完全避免缺失值。
- SRI应用的信度、收敛效度和区分效度得到建立。
核心结论
- SRI应用是实用且接受度良好的工具,可完全避免缺失值,并建立了信度、收敛效度和区分效度。
研究设计与样本
- 随机对照试验,纳入60例慢性呼吸衰竭患者,比较SRI应用与经典纸质SRI。
主要发现
- SRI应用实用且接受度良好,使用该应用可完全避免缺失值。
- 信度、收敛效度和区分效度得到建立。
- 各SRI子量表的Cronbach's alpha:应用为0.56至0.81,纸质为0.54至0.83。
关键数值与推荐
- 各SRI子量表的Cronbach's alpha:应用为0.56至0.81,纸质为0.54至0.83。
- 多语言SRI应用可免费用于非营利研究目的。
临床怎么用
- 在慢性呼吸衰竭患者中可使用SRI应用替代纸质SRI,以减少缺失值并便于数据收集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An application (app) for the Severe Respiratory Insufficiency Questionnaire (SRI) has been designed and developed for mobile devices. In a randomised controlled trial comprising 60 patients with chronic respiratory failure, the app was compared with the classic paper SRI. Thereby, it was shown that the SRI app is a practical tool that is well accepted. Missing values can be completely avoided by using the SRI app. Finally, reliability, convergent and discriminant validities were established. Accordingly, for the individual SRI subscales, Cronbach's alpha ranged between 0.56 and 0.81 (app) and between 0.54 and 0.83 (paper), respectively. The multilingual SRI app is accessible free of charge for non-profit research purposes.
引用
- Majorski DS, Schwarz SB, Magnet FS, et al. The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial. Thorax. 2021. PMID: 33653932. doi:10.1136/thoraxjnl-2020-216319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。